Semaglutide Weight Management
Sustained weight loss through appetite regulation and metabolic improvement
A structured titration protocol using semaglutide (GLP-1 receptor agonist) for weight management. FDA-approved for obesity, this protocol follows the clinical dose escalation schedule to minimize GI side effects.
Peptides Involved
💉 Dosing Schedule
Dose
0.25 mg → 0.5 mg → 1.0 mg → 2.4 mg/week
Frequency
Once weekly subcutaneous injection
Timing
Same day each week, any time of day
📅 Cycle Structure
Ongoing Therapy
Ongoing therapy (no cycling required)
📊 Phase Breakdown
Titration Phase 1
Weeks 1–40.25 mg/week — assess tolerance, expect mild nausea
Titration Phase 2
Weeks 5–80.5 mg/week — appetite suppression becomes noticeable
Titration Phase 3
Weeks 9–121.0 mg/week — significant weight loss typically begins
Maintenance Phase
Week 13+1.0–2.4 mg/week — titrate up only if tolerated and needed
💡 Notes & Tips
- Prioritize protein intake (1 g/lb body weight) to preserve muscle mass
- Combine with resistance training for optimal body composition
- Stay hydrated — minimum 2–3 liters of water daily
- Each dose level should be maintained a minimum of 4 weeks before increasing
- Report persistent nausea, vomiting, or abdominal pain to your physician
Medical Disclaimer
This protocol is for informational purposes only. Dosing guidelines are based on community reports and limited research — not clinical trials. Always consult a qualified healthcare provider before starting any peptide protocol.